Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gamisoyosan for Generalized Anxiety Disorder
NCT01285115Phase 3Completed
- Sponsor
- Korea Health Industry Development Institute
- Start
- Dec 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gamisoyosan in generalized anxiety disorder (GAD), sponsored by Korea Health Industry Development Institute. Started Dec 2008; status: completed.
02
Drugs
gamisoyosan
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT01285115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01285115.